Clinical Trials Browser

OTHER × Advanced Hepatocellular Carcinoma × cabozantinib × Clear all

NCT04442581 2023-04-05

Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer

Phase 2 Terminated

2 enrolled 12 charts

Gastrointestinal

Advanced Hepatocellular Carcinoma